State of New Jersey Common Pension Fund D’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-176,710
Closed -$2.74M 1764
2021
Q2
$2.74M Buy
176,710
+52,454
+42% +$835K 0.01% 1181
2021
Q1
$2.01M Sell
124,256
-17,009
-12% -$303K 0.01% 1561
2020
Q4
$2.99M Sell
141,265
-18,323
-11% -$318K 0.01% 1082
2020
Q3
$2.37M Buy
159,588
+36,988
+30% +$577K 0.01% 1081
2020
Q2
$1.8M Buy
122,600
+13,383
+12% +$220K 0.01% 1515
2020
Q1
$1.28M Hold
109,217
0.01% 1325
2019
Q4
$2.57M Sell
109,217
-14,983
-12% -$331K 0.01% 1148
2019
Q3
$2.3M Buy
+124,200
New +$2.29M 0.01% 1264

Other funds holding HRTX

State of New Jersey Common Pension Fund D's HRTX Position: Q3 2021 in Review

State of New Jersey Common Pension Fund D sold out of Heron Therapeutics (HRTX) in Q3 2021, closing a stake of 176,710 shares — an estimated $2.74M sold.

State of New Jersey Common Pension Fund D first reported a position in HRTX in Q3 2019 and held it in 8 quarters. The position peaked at $2.99M in Q4 2020. 197 funds tracked by Wall St. Rank hold HRTX as of Q3 2021.

  • State of New Jersey Common Pension Fund D reported no remaining Heron Therapeutics position as of Q3 2021 after selling out during the quarter.
  • State of New Jersey Common Pension Fund D sold 176,710 Heron Therapeutics shares in Q3 2021, an estimated $2.74M.
  • State of New Jersey Common Pension Fund D first reported a position in Heron Therapeutics in Q3 2019 and held it in 8 quarters.
  • State of New Jersey Common Pension Fund D's Heron Therapeutics position peaked at $2.99M in Q4 2020.
  • 197 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2021.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2021, filed 27 Oct 2021.